|
|
Effects of resveratrol soft capsules on diabetic patients’s blood sugar and early retinopathy |
ZHANG Xian1, and LIU Li2 |
1.Milltary Ward,2.Department of Medicine,Yunnan Provincial Corps Hospital, Chinese People's Armed Police Force,Kunming 650111,China |
|
|
Abstract Objective To study the efficacy of resveratrol soft capsules on fasting blood glucose and early diabetic retinopathy(DR).Methods 60 diabetic patients with DR were randomly divided into 4 groups: A, C, B and D by using digital table method.15 cases in each group.The first three groups received basic treatment plus resveratrol soft capsules, Group A: 250 mg/ead time, orally, twice/day; Group B: 350 mg/each times, orally,twice/day; Group C: 500 mg/each time, orally, twice/day for 12 weeks. D group was the control group (basic treatment: exercise intervention, diet control, insulin and oral hypoglycemic agents), compared before and after treatment 1,8,10,12 weekend DR fasting glucose.And before medication and 12 weeks,retinal fluorescein angiography (fundus fluorescence angiography FFA) was used to detect microvascular changes in the patient’s capillary hemangioma,hemorrhage and leakage area for comparison.Results In C group,after treatment ,FPG(8.6±0.812)mmol/L ratio(6.7±0.714)mmol/L,t=4.752,P=0.037;HbALc:(8.7±0.341)% versus(7.2±0.426)%,t=5.542,P=0.031,ISN:(32.4 ± 0.341)pmol/ml versus (28.3±0.132) pmol/ml,t=6.459,P=0.038,In after group C and D, capillary hemangioma, hemorrhage focal area and leaking focal area were (16.86±1.75)N versas (10.06±1.29)N,t=4.624, P<0.05;(2.24±0.23)mm2 versas(1.45±0.22) mm2,t=2.532, P<0.05,(1.40±0.15) mm2 versas(1.01±0.23) mm2,t=2.605, P<0.05.After treatment, the number of capillary hemangioma was decreased, the area of hemorrhage and the area of leakage were reduced.Conclusions The effect of resveratrol on blood glucose and early retinopathy in diabetic patients is dose dependent,and the effective rate in group C is better than that in group B, and group B was better than groups A and D.
|
Received: 29 March 2016
|
|
|
|
|
[1] |
惠延年,王 琳.糖尿病视网膜病变和黄斑水肿的国际临床分类法[J].国际眼科杂志,2004,4(5):56-59.
|
[2] |
郑筱萸.中药新药临床研究指导原则(试行)[M].北京: 中国医学科技出版社,2002:99-104.
|
[3] |
李青春,李 岱.白藜芦醇对眼部疾病防治机制的研究进展[J]. 实用医学杂志,2014,30(24):4044-4046.
|
[4] |
Williams R,Airey M,Baxter H,et al.Epidemiology of diabetic retinopathyand and macular oedema:a systematic review[J]. Eye,2004,18(10) :963-983.
|
[5] |
Xia N,Daiber A,Habermeier A,et al. Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice[J]. J Pharmacol Exp Ther,2010,335(1):149-154.
|
[6] |
孔祥菊,赵 璐,李国强.白藜芦醇降低妊娠期糖尿病大鼠血糖的作用及机制研究[J].哈尔滨医科大学学报,2014,8(48):286-287.
|
[7] |
张皎月,陈璐璐,郑 涓,等.白藜芦醇改善高脂饲养小鼠胰岛功能的观察[J].中国糖尿病杂志,2013,6,(21):551-553.
|
[8] |
Lee J H,Song M Y,Song E K,et al.Overexpression of SIRT1 protects pancreatic betta-cells against cytokine toxicity by suppressing the nuclearfactor-kappaB signaling pathway[J].Diabetes,2009,58(2):344-351.
|
[9] |
Um J H,Park S J,Kang H,et al.AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol[J].Diabetes,2010,59(3):554-563.
|
[10] |
Wan T T,Li X F,Sun Y H, et al.Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy[J].Biomed Pharmacother,2015,74(1):145-147.
|
|
|
|